Our Support in Your Fight against Cancer
According to the World Health Organization, Cancer is the second leading cause of death globally. Moreover, the WHO projects the number of global cancer deaths to increase by 45% between 2008 and 2030.
In respond to these rising numbers, the numbers of anti-cancer treatments will rise as well. Facing this global cancer burden, B. Braun supports the healthcare workforce worldwide to enable safe treatment of current and future patients. Oncology is a field of medical specialization using the full range of armamentarium of therapeutic approaches including nuclear therapy, surgery, radiation, etc. Infusion of anti-cancer drugs remains a mainstay of the therapy, whereby most of the drugs applied are exerting their effects as cytostatics or cytotoxics. As anti-cancer treatment is a highly specialized and diversified field of therapies and brings along a range of inherent risks both for patients as well as for healthcare workers, all process steps require special attention, care, knowledge and appropriately safe products.